Seth Klarman
Baupost Group
Baupost Group Portfolio 13F
Seth Klarman Holdings Activity
- Portfolio value:
- $8.83B≈ (-$2B≈)
- Previous value:
- $11.05B≈
- # of changes:
- 23
- New positions:
- 3
- Reported for:
- 30 Sep 2019 (Q3)
- Latest filing date:
- 13 Nov 2019
Baupost Group has disclosed a total of 23 changes to the portfolio in the (2019 Q3) SEC report(s): increased the number of shares of 6, bought 3 totally new, decreased the number of shares of 11 and completely sold out 3 position(s).
What stocks did Seth Klarman buy in 2019 Q3?
During 2019 Q3 Seth Klarman has bought 9 securities out of which top 5 purchases (by % change to portfolio) were (LBTYK) Liberty Global PLC, CL-C (added shares +4.82%), (PARA) Paramount Global, CL-B (added shares +20.00%), (NXST) Nexstar Broadcasting Group Inc (added shares +43.09%), (LBTYA) LIBERTY GLOBAL HOLDINGS LTD/ (added shares +2.91%) and (TBIO-OLD) TRANSLATE BIO INC (added shares +98.37%).
23 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cars.com Inc
|
new
|
$8.98
|
+35.08%($12.13)
|
0.31%
|
2019 Q3
|
≈ 0.25 years
|
||||
|
|
Nuance Communications Inc
|
new
|
$16.31
|
|
1.52%
|
2019 Q3
|
≈ 0.25 years
|
||||
|
|
Vista Oil Gas ADR
|
new
|
$5.17
|
+1,175.62%($65.95)
|
0.36%
|
2019 Q3
|
≈ 0.25 years
|
||||
|
|
TRANSLATE BIO INC
|
+98.37%
|
$9.82
|
|
1.95%
|
2018 Q2
|
≈ 1.50 years
|
||||
|
|
Nexstar Broadcasting Group Inc
|
+43.09%
|
$102.31
|
+90.20%($194.60)
|
2.32%
|
2018 Q4
|
≈ 1.00 year
|
||||
|
|
Paramount Global, CL-B
|
+20.00%
|
$40.37
|
|
5.49%
|
2018 Q4
|
≈ 1.00 year
|
||||
|
|
Atara Biotherapeutics Inc
|
+18.70%
|
$14.12
|
-37.54%($8.82)
|
1.33%
|
2014 Q4
|
≈ 5.00 years
|
||||
|
|
Liberty Global PLC, CL-C
|
+4.82%
|
$23.79
|
-56.09%($10.44)
|
11.84%
|
2018 Q3
|
≈ 1.25 years
|
||||
|
|
LIBERTY GLOBAL HOLDINGS LTD/
|
+2.91%
|
$24.75
|
-56.22%($10.84)
|
2.15%
|
2018 Q3
|
≈ 1.25 years
|
||||
|
|
Takeda Pharmaceutical Co Ltd ADR
|
-0.03%
|
$17.20
|
-3.34%($16.62)
|
1.84%
|
2019 Q1
|
≈ 0.75 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.